Skip to main content
Back to Google Ventures

Google Ventures's Biotechnology Portfolio

Browse 60 Biotechnology companies funded by Google Ventures. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
60
Total Funding in Biotechnology
$5.6B

Biotechnology Portfolio Companies (60)

Export
Big DataBiotechnologyFood and BeverageReal TimeSensorSupply Chain ManagementSustainabilityWaste Management

Strella Biotechnology offers a biosensing platform that predicts the ripeness of fruit which reduces food waste and improves quality.

Philadelphia, United States
September 2024
$5.6M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Waltham, United States
July 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Cambridge, United States
July 2023
$25.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

South San Francisco, United States
June 2026
$345.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyEmergency MedicineMedical

Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.

Palo Alto, United States
June 2023
$145.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

San Francisco, United States
June 2023
$35.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Cambridge, United States
May 2026
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Cambridge, United States
May 2026
$275.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyFood and BeverageFood ProcessingNutritionSustainability

Air Protein develops protein-enriched food made from CO2.

Pleasanton, United States
May 2023
$75.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceProduct Research

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Seattle, United States
May 2026
$69.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyFertilityHealth CareTherapeutics

Granata Bio is a biotechnology company developing therapeutic solutions to address infertility and improve women's reproductive health.

Duxbury, United States
May 2025
Corporate Round

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyVeterinary

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

Boston, United States
May 2022
$60.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.

Cambridge, United States
April 2025
$121.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalWellness

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Cambridge, United States
April 2026
$100.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Del Mar, United States
April 2023
$53.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyEmergency MedicineGeneticsHealth CarePrecision Medicine

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Cambridge, United States
March 2022
$83.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife ScienceTherapeutics

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

Cambridge, United States
March 2022
$175.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

Hayward, United States
March 2022
$36.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.

Oxford, United Kingdom
March 2023
$4.1M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Cambridge, United Kingdom
March 2026
$40.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

London, United Kingdom
February 2024
$350.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Alternative ProteinBiotechnologyFood and BeverageFood Processing

Evergreen develops a scalable and sustainable approach to producing cultured meat.

Los Angeles, United States
February 2026
$6.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

San Francisco, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyProduct Research

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Boston, United States
February 2023
$193.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Bernardsville, United States
February 2024
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyFertilityHealth Care

Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures.

Alcobendas, Spain
April 2025
$20.6M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyChemicalIndustrial ManufacturingManufacturing

Again is a carbon utilization company that focuses on transforming carbon emissions into valuable chemicals.

Copenhagen, Denmark
July 2024
$43.1M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceSoftware

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

New York, United States
July 2024
$28.2M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Alameda, United States
June 2024
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Accent Therapeutics is a biopharmaceutical company.

Lexington, United States
January 2024
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Our purpose is to make every pregnancy around the world safer.

Concord, United States
January 2024
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

San Francisco, United States
January 2024
$57.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

San Francisco, United States
January 2022
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsTherapeutics

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

San Francisco, United States
December 2025
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

Cambridge, United States
December 2022
$25.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Boston, United States
December 2022
$60.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

San Francisco, United States
December 2025
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

Cambridge, United Kingdom
November 2021
$88.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.

Basel, Switzerland
January 2025
$86.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

South San Francisco, United States
December 2025
$261.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceNanotechnology

Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.

Brisbane, United States
November 2025
$65.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

Isomorphic Labs provides AI-driven solutions for drug discovery and development.

London, United Kingdom
March 2025
$600.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Waltham, United States
December 2024
$30.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalNeuroscienceTherapeutics

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Boston, United States
April 2024
$47.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedical

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Watertown, United States
December 2023
$213.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Cambridge, United States
September 2023
$72.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical DeviceTherapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Cambridge, United States
September 2022
$9.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for infectious diseases and cancer.

Harwell, United Kingdom
March 2021
$168.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsPrimary and Urgent CareSoftware

Imagen is a healthcare organization that provides onsite and diagnostic solutions to maximize clinical outcomes and patient satisfaction.

New York, United States
February 2021
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

IconOVir Bio is a preclinical-stage biotechnology company developing oncolytic virus therapy for the treatment of patients with cancer.

New York, United States
January 2021
$77.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

San Diego, United States
December 2020
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePersonal HealthPharmaceutical

Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.

Hayward, United States
January 2020
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncology

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

Palo Alto, United States
August 2019
$6.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareNeuroscienceTherapeutics

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

San Francisco, United States
June 2019
$76.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

Waltham, United States
April 2019
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Cambridge, United States
September 2017
$27.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife Science

Genomics Medicine Ireland is an Irish life sciences company conducting a study across Ireland of the human genome.

Dublin, Ireland
October 2016
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Zephyr Health operates as an insights-as-a-service solution built specifically for life sciences companies.

San Francisco, United States
August 2015
$17.5M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

Cambridge, United States
January 2013
$13.5M
Series B

Founder Contacts

30,000+ verified contacts

Explore Google Ventures's Full Portfolio

View all companies funded by Google Ventures across every industry and funding stage.

View Full Google Ventures Portfolio